Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.76 USD | +0.90% | -0.60% | -6.07% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.07% | 3.52B | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
-10.35% | 34.47B | |
+64.64% | 26.7B | |
-16.15% | 15.13B | |
-6.98% | 13.27B | |
-11.77% | 11.74B | |
-49.19% | 10.54B | |
+8.09% | 9.41B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Transcript : Axsome Therapeutics, Inc., Q4 2023 Earnings Call, Feb 20, 2024